Theriva Biologics, Inc. (TOVX)
Theriva Biologics Market Cap : 6.608M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2026 | 6.608M |
| November 17, 2026 | 6.425M |
| November 16, 2026 | 6.425M |
| November 13, 2026 | 6.613M |
| November 12, 2026 | 7.343M |
| November 11, 2026 | 7.384M |
| November 10, 2026 | 7.077M |
| November 09, 2026 | 7.609M |
| November 06, 2026 | 7.641M |
| November 05, 2026 | 7.728M |
| November 04, 2026 | 8.720M |
| November 03, 2026 | 8.352M |
| November 02, 2026 | 8.444M |
| October 30, 2026 | 7.825M |
| October 29, 2026 | 8.582M |
| October 28, 2026 | 8.715M |
| October 27, 2026 | 8.628M |
| October 26, 2026 | 8.876M |
| October 23, 2026 | 8.995M |
| October 22, 2026 | 8.720M |
| October 21, 2026 | 9.022M |
| October 20, 2026 | 9.546M |
| October 19, 2026 | 9.394M |
| October 16, 2026 | 9.541M |
| October 15, 2026 | 9.729M |
| Date | Value |
|---|---|
| October 14, 2026 | 9.633M |
| October 13, 2026 | 9.899M |
| October 12, 2026 | 10.07M |
| October 09, 2026 | 9.959M |
| October 08, 2026 | 10.42M |
| October 07, 2026 | 10.74M |
| October 06, 2026 | 10.19M |
| October 05, 2026 | 10.33M |
| October 02, 2026 | 10.33M |
| October 01, 2026 | 10.33M |
| September 30, 2026 | 10.33M |
| September 29, 2026 | 9.638M |
| September 28, 2026 | 9.936M |
| September 25, 2026 | 10.12M |
| September 24, 2026 | 10.58M |
| September 23, 2026 | 10.77M |
| September 22, 2026 | 10.59M |
| September 21, 2026 | 10.59M |
| September 18, 2026 | 10.72M |
| September 17, 2026 | 11.11M |
| September 16, 2026 | 10.37M |
| September 15, 2026 | 10.33M |
| September 14, 2026 | 10.81M |
| September 11, 2026 | 11.36M |
| September 10, 2026 | 11.14M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.081B |
| Alnylam Pharmaceuticals, Inc. | 20.00B |
| Anika Therapeutics, Inc. | 182.43M |
| Savara, Inc. | 970.13M |
| Arrowhead Pharmaceuticals, Inc. | 6.091B |
Market Cap Related Metrics
| PS Ratio | 20.23 |
| Price to Book Value | 0.6146 |
| Price | 0.144 |
| Earnings Yield | -173.7% |